Abstract
Introduction
CD91 is a member of the Low-density lipoprotein receptor family that recognizes more than 40 structurally and functionally distinct ligands. 1 Particularly, CD91 has been demonstrated to bind and internalize α 2 -Macroglobulin, 2 C1q 3 and defensins. 4 Reflecting this diversity of ligands, CD91 displays a wide tissue distribution and participates in a variety of physiological responses, including lipoprotein metabolism, proteinase homeostasis and cell migration.
Subsequent studies defined CD91 as an immunologically relevant receptor for Heat Shock
Proteins (HSPs) and molecular chaperones. 5, 6 It is expressed on different cell types, including dendritic cells, monocytes, macrophages, B and T cells as well as splenocytes and thymocytes. 7 In addition, CD91 is expressed on monocyte-derived dendritic cells (moDCs) and it plays a role in the internalization of CD91-targeted antigens and their presentation to T cells. 8 Moreover, the importance of this molecule in the immune response has been strengthened by the observation that CD91 represents an important route for stimulating CD8 + T cell responses by MHC class I-restricted presentation. 
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The scavenger receptor CD91 is involved in wide a variety of diseases and infections.
Kebba et al, showed that a significantly higher surface expression of CD91 on monocytes of human immunodeficiency virus type-1 (HIV-1)-infected long-term nonprogressors may contribute to host anti-HIV-1 defence and play a role in protection against HIV-1 infection. 10 Further, the up-regulation of CD91 in patients affected by cancer may represent an additional strategy to improve DC activation and subsequent stimulation of a specific CD8+
T cell response towards tumor cells dying an immunogenic cell death. 11 Of note, CD91 In a previous study, we demonstrated that moDCs express CD91 and that moDC treatment with human defensins up-regulates the surface expression of CD91 as well as the activation/maturation markers on these cells. 15 In this study, we described two subsets of moDCs, characterized by variable level of CD91 expression and different state of activation/maturation. We further investigated the effects of recombinant human alpha and beta defensins, Human Neutrophil Peptide-1 (HNP-1) and Human Beta Defensin-1 (rHBD-1), on these two subsets of moDCs.
Materials and Methods

In vitro culture of moDCs
Human peripheral blood mononuclear cells (PBMCs) were isolated by Ficoll density gradient centrifugation from standard buffy coat preparations of healthy donors. Monocytes were obtained from adherent PBMCs (> 90% pure CD14 + , as assessed by flow cytometry) and cultured in RPMI-1640 (Euroclone, Wetherby, UK) supplemented with 10% heat-inactivated
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Flow cytometric analysis
Phenotypic analysis was performed by 5-color flow cytometry. Briefly, 1x10 5 To optimize the staining, mAbs were titrated in preliminary experiments. 7-Aminoactinomycin D (7-AAD, Sigma Aldrich) was used to exclude non-viable cells from the analysis. Fluorescence minus one (FMO) samples were used as negative controls.
Cells were collected and analyzed using a FACSCanto II (Becton Dickinson) flow cytometer, and data analysis was performed using FACSDiva (Becton Dickinson) and FlowJo software (TreeStar Inc., Ashland, OR, USA).
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Statistical analysis
Statistical analyses were performed using GraphPad Prism 5.0a (GraphPad Software, San Diego, CA). All statistical analyses assumed a two-sided significance level of p< 0.05. The
Student's paired t-test was used for comparisons between groups.
Results
Different levels of CD91 identify two moDC subpopulations
Others and we previously showed that CD91 is expressed on moDCs. 9, [15] [16] [17] However, whether CD91 is expressed differently in moDC subpopulations is still unknown. To investigate the expression of CD91 receptor, we cultured human monocytes with GM-CSF and IL-4 for 5 days to generate immature moDCs that were subsequently characterized by flow cytometry. As expected, 15 we observed that during the differentiation of monocytes into moDCs characterized by down-regulation of CD14 and up-regulation of CD1a ( Figure 1A ), a partial down-regulation of CD91 occurred in parallel ( Figure 1B) . Moreover, our results clearly showed that CD91 + moDCs are segregated into two distinct populations: CD91 is highly expressed in a small proportion of total moDCs (CD91 bright moDCs) (mean ± SE, 1.19% ± 0.28), while the majority of cells expressed low levels of CD91 receptor (CD91 dim moDCs) (Figure 2A ).
CD91 bright moDCs show an activated phenotype
The ability of DCs to activate immune responses depends on their maturation status and the expression of costimulatory molecules. In order to investigate whether CD91 bright and CD91 dim subsets differ in term of activation/maturation, we evaluated their surface expression of CD80, CD86, CD40, CD83, HLA-DR molecules. As shown in Figure 2B ,
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Discussion
DCs are potent antigen presenting cells that sense environmental stimuli through a wide repertoire of receptors expressed on their surface. 18 We and others previously described that moDCs express CD91, a polyfunctional receptor that binds several molecules including defensins. 4, 9, [15] [16] [17] In this study we confirmed our previous observations and, by using multiparametric flow cytometry analysis, we showed for the first time to our knowledge the presence of two distinct subsets of moDCs based on their CD91 expression: CD91 bright and CD91 dim moDCs. These subsets were characterized by a different phenotype. In fact, although CD91 bright cells represented a small proportion of moDCs, this subset showed a
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This article is protected by copyright. All rights reserved. 19, 20 we observed that HSP90 decreased the frequency of CD91 bright moDCs. Not even the ability of defensins to up-regulate CD91 was shared by LPS, a common proinflammatory molecule that signals through toll-like receptor 4. Indeed, also LPS decreased the frequency of CD91 bright moDCs. This finding is in accordance with our previous study, 15 reporting LPS-induced down-regulation of CD91 expression on moDCs, possibly supported by shedding of CD91 from cell surface. 21 Although there are evidences that CD91-mediated immune activation can represent a powerful mechanism of immune regulation, the pathway/s regulating expression of CD91
have not been fully defined so far. CD91 is up-regulated on monocytes of HIV + long term nonprogressor subjects, it may enhance cross-presentation of HIV antigens and may in turn enhance the stimulation of activated anti-HIV CTLs. 22 Moreover, the pivotal role of CD91
regulation on DCs has been demonstrated in the context of primary effusion lymphoma: DC activation was completely inhibited when these cells were pre-treated with a neutralizing antibody directed against CD91, 11 thus suggesting that the up-regulation of CD91 in cancer patients may represent an additional strategy to improve DC activation and subsequent
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